Detalhe da pesquisa
1.
Cloned IGH VDJ targets as tools for personalized minimal residual disease monitoring in mature lymphoid malignancies; a feasibility study in mantle cell lymphoma by the Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang.
Br J Haematol
; 158(2): 186-197, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22626453